Influence of Patient Race on Physician Prescribing Decisions: A Randomized On-Line Experiment

  • Saif S. Rathore
  • Jonathan D. Ketcham
  • G. Caleb Alexander
  • Andrew J. Epstein
Original Article

ABSTRACT

BACKGROUND

Prior research reports black patients have lower medication use for hypercholesterolemia, hypertension, and diabetes.

OBJECTIVE

To assess whether patient race influences physicians’ prescribing.

DESIGN

Web-based survey including three clinical vignettes (hypercholesterolemia, hypertension, diabetes), with patient race (black, white) randomized across vignettes.

SUBJECTS

A total of 716 respondents from 5,141 eligible sampled primary care physicians (14% response rate).

INTERVENTIONS

None

MEASUREMENTS

Medication recommendation (any medication vs none, on-patent branded vs generic, and therapeutic class) and physicians’ treatment adherence forecast (10-point Likert scale, 1—definitely not adhere, 10—definitely adhere).

RESULTS

Respondents randomized to view black patients (n = 371) and white patients (n = 345) recommend any medications at comparable rates for hypercholesterolemia (100.0% white vs 99.5% black, P = 0.50), hypertension (99.7% white vs 99.5% black, P = 1.00), and diabetes (99.7% white vs 99.7% black, P = 1.00). Patient race influenced medication class chosen in the hypertension vignette; respondents randomized to view black patients recommended calcium channel blockers more often (20.8% black vs 3.2% white) and angiotensin-converting enzyme inhibitors less often (47.4% black vs 62.6% white) (P < 0.001). Patient race did not influence medication class for hypercholesterolemia or diabetes. Respondents randomized to view black patients reported lower forecasted patient adherence for hypertension (P < 0.001, mean: 7.3 black vs 7.7 white) and diabetes (P = 0.05 mean: 7.4 black vs 7.6 white), but race had no meaningful influence on forecasted adherence for hypercholesterolemia (P = 0.15, mean: 7.2 black vs 7.3 white).

CONCLUSION

Racial differences in outpatient prescribing patterns for hypertension, hypercholesterolemia, and diabetes are likely attributable to factors other than prescribing decisions based on patient race.

KEY WORDS

patient race prescription medication hypertension hypercholesterolemia diabetes 

Notes

Acknowledgments

Harris Interactive implemented the survey and participated in its design. Survey costs and the authors’ time were funded by Pfizer Inc. The authors performed this analysis independently of the funder and retained full control of all aspects of the analysis, including survey design, data analysis and interpretation, preparation of the manuscript, and submission decisions.

Dr. Alexander has career development awards from the Agency for Healthcare Research and Quality (K08 HS15699-01A1) and the Robert Wood Johnson Physician Faculty Scholars Program.

The funding sources had no role in the design and conduct of the study, analysis or interpretation of the data; and preparation or final approval of the manuscript prior to publication.

The authors have no conflicts of interest to report.

References

  1. 1.
    Agency for Healthcare Research Quality. (Agency for Healthcare Research and Quality). National Healthcare Disparities Report 2007. 2008.Google Scholar
  2. 2.
    Nelson K, Norris K, Mangione C. Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2002; 162: 929–35.CrossRefPubMedGoogle Scholar
  3. 3.
    Sequist TD, Fitzmaurice GM, Marshall R, Shaykevich S, Safran DG, Ayanian JZ. Physician performance and racial disparities in diabetes mellitus care. Arch Intern Med. 2008; 168: 1145–51.CrossRefPubMedGoogle Scholar
  4. 4.
    Virnig BA, Lurie N, Huang Z, Musgrave D, McBean AM, Dowd B. Racial variation in quality of care among Medicare + Choice enrollees. Health Aff. 2002; 21: 224–30.CrossRefGoogle Scholar
  5. 5.
    Trivedi AN, Zaslavsky AM, Schneider EC, Ayanian JZ. Trends in the quality of care and racial disparities in Medicare managed care. N Engl J Med. 2005; 353: 692–700.CrossRefPubMedGoogle Scholar
  6. 6.
    Gellad WF, Haas JS, Safran DG. Race and non-adherence to prescription medications among seniors: results of a national survey [abstract]. J Gen Intern Med. 2006; 21: 115–6.Google Scholar
  7. 7.
    Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL. Primary care physicians who treat blacks and whites. N Engl J Med. 2004; 351: 575–84.CrossRefPubMedGoogle Scholar
  8. 8.
    Smedley BD, Stith AY, Nelson AR. (Institute of Medicine). Unequal treatment: confronting racial and ethnic disparities in health care. 2002.Google Scholar
  9. 9.
    Rathore SS, Krumholz HM. Differences, disparities, and biases: clarifying racial variations in health care use. Ann Intern Med. 2004; 141: 635–8.PubMedGoogle Scholar
  10. 10.
    Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians’ recommendations for cardiac catheterization. N Engl J Med. 1999; 340: 618–26.CrossRefPubMedGoogle Scholar
  11. 11.
    Epstein AJ, Rathore SS, Alexander CG, Ketcham JJ. Primary care physicians’ views of Medicare Part D. Am J Managed Care. 2008; SP14: 5–13.Google Scholar
  12. 12.
    Alexander CS, Becker HJ. The use of vignettes in survey research. Pub Opin Q. 1978; 42: 93–104.CrossRefGoogle Scholar
  13. 13.
    Veloski J, Tai S, Evans AS, Nash DB. Clinical vignette-based surveys: a tool for assessing physician practice variation. Am J Med Qual. 2005; 20: 151–7.CrossRefPubMedGoogle Scholar
  14. 14.
    Kramer H, Han C, Post W, et al. Racial/ethnic differences in hypertension and hypertension treatment and control in the Mult-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens. 2004; 17: 963–70.CrossRefPubMedGoogle Scholar
  15. 15.
    Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003; 163: 525–41.CrossRefPubMedGoogle Scholar
  16. 16.
    Seghal AR. Overlap between whites and blacks in response to antihypertensive drugs. Hypertension. 2004; 43: 566–72.CrossRefGoogle Scholar
  17. 17.
    Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289: 2560–71.CrossRefPubMedGoogle Scholar
  18. 18.
    Weisse CS, Sorum PC, Sanders KN, Syat BL. Do gender and race affect decisions about pain management? J Gen Intern Med. 2001; 16: 211–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Rathore SS, Lenert LA, Weinfurt KP, et al. The effects of patient sex and race on medical students’ ratings of quality of life. Am J Med. 2000; 108: 561–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004; 110: 227–39.CrossRefPubMedGoogle Scholar
  21. 21.
    Balsa AI, McGuire TG, Meredith LS. Testing for statistical discrimination in health care. Health Serv Res. 2005; 40: 227–52.CrossRefPubMedGoogle Scholar
  22. 22.
    van Ryn M. Research on the provider contribution to race/ethnicity disparities in medical care. Med Care. 2002; 40: I140–51.PubMedGoogle Scholar
  23. 23.
    Goldstein CE, Hebert PE, Sisk JE, McLaughlin MA, Horowitz CR, McGinn TG. Hypertension management in minority communities: a clinician survey. J Gen Intern Med. 2008; 23: 81–6.CrossRefPubMedGoogle Scholar
  24. 24.
    Monane M, Bohn RL, Gurwitz J, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996; 86: 1805–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Peabody JW, Luck J, Glassman P, Dresselhaus TR, Lee M. Comparison of vignettes, standardized patients, and chart abstraction. JAMA. 2000; 283: 1715–22.CrossRefPubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 2009

Authors and Affiliations

  • Saif S. Rathore
    • 1
  • Jonathan D. Ketcham
    • 2
  • G. Caleb Alexander
    • 3
    • 4
    • 5
    • 6
  • Andrew J. Epstein
    • 7
    • 8
  1. 1.MD/PhD Program, SHM IE-61Yale University School of MedicineNew HavenUSA
  2. 2.W.P. Carey School of BusinessArizona State UniversityTempeUSA
  3. 3.Center for Health and Social SciencesUniversity of ChicagoChicagoUSA
  4. 4.General Internal Medicine Section, Department of MedicineUniversity of ChicagoChicagoUSA
  5. 5.MacLean Center for Clinical Medical EthicsUniversity of ChicagoChicagoUSA
  6. 6.Department of Pharmacy PracticeUniversity of Illinois at Chicago School of PharmacyChicagoUSA
  7. 7.Section of Health Policy and Administration, Department of Epidemiology and Public HealthYale University School of MedicineNew HavenUSA
  8. 8.Leonard Davis Institute of Health EconomicsUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations